ClassID:

95991

C07F9/4075 - CPC Classification

Classification description:

Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds with one or more P—C bonds; Phosphonic acids RP(=O)(OH); Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se); Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic Esters with hydroxyalkyl compounds

Recent Application in this class:
#1
20260142246
2026-05-21

Monomer for Electrolyte, Electrolyte for Secondary Battery Including the Same, Method of Preparing the Same and Lithium Secondary Battery Including the Same

#2
20230303598
2023-09-28

BIOINSPIRED LIPID DERIVATIVES AND USES THEREOF

#3
20230115651
2023-04-13

Prodrugs of prostate specific membrane antigen (PSMA) inhibitor

#4
20220166064
2022-05-26

ELECTROLYTE ADDITIVE

#5
20200399298
2020-12-24

Prodrugs of prostate specific membrane antigen (PSMA) inhibitor

#6
20200079804
2020-03-12

Process for producing phosphinates

#7
20190359644
2019-11-28

PROCESSES AND INTERMEDIATES FOR PREPARING ANTI-HIV AGENTS

#8
20190076358
2019-03-14

Biodegradable compound, lipid particle, composition containing lipid particle, and kit

#9
20180370998
2018-12-27

Aminobisphosphonate antiwear additives

#10
20180282354
2018-10-04

Supported molybdenum peroxo complexes for transforming organo phosphate neurotoxins to a value-added, commodity phosphorus chemical

#11
20180265529
2018-09-20

Process for producing phosphinates

#12
20180244705
2018-08-30

Prodrugs of prostate specific membrane antigen (PSMA) inhibitor

#13
20180099985
2018-04-12

AminoBisPhosphonate antiwear additives

#14
20180079773
2018-03-22

Processes and intermediates for preparing anti-HIV agents

#15
20170226141
2017-08-10

Prodrugs of prostate specific membrane antigen (PSMA) inhibitor

#16
20160340379
2016-11-24

Processes and intermediates for preparing anti-HIV agents

#17
20150344450
2015-12-03

Synthesis, structure and use of functionalized naphthalenes

#18
20150274915
2015-10-01

Organophosphorus compounds for flame retardant polyurethane foams

#19
20150203525
2015-07-23

Processes and intermediates for preparing anti-HIV agents

#20
20150025039
2015-01-22

Antiviral phosphonate analogs

#21
20140272556
2014-09-18

Non-aqueous electrolyte solution containing phosphonosulfonic acid compound, and lithium secondary battery

#22
20140046018
2014-02-13

Biodegradable polymer—bioactive moiety conjugates

#23
20140044775
2014-02-13

Synthetic lung surfactant and use thereof

#24
20130315841
2013-11-28

Functionalized naphthalene fluorophores

#25
20130310558
2013-11-21

Synthesis, structure and use of functionalized naphthalenes

#26
20130274479
2013-10-17

Aminohydroxylation of alkenes

#27
20120309986
2012-12-06

Process for the preparation of chymase modulators

#28
20120296076
2012-11-22

Processes and intermediates for preparing anti-HIV Agents

#29
20120258935
2012-10-11

Process for preparation of HIV protease inhibitors

#30
20120142897
2012-06-07

Phosphonates synthons for the synthesis of phosphonates derivatives showing better bioavailability

#31
20120123025
2012-05-17

Mixed phosphonate flame-retardants

#32
20110294018
2011-12-01

Redox shuttles for high voltage cathodes

#33
20110288053
2011-11-24

ANTIVIRAL PHOSPHONATE ANALOGS

#34
20110245512
2011-10-06

Hydroxylated contrast enhancement agents

#35
20110243884
2011-10-06

Biodegradable polymer—bioactive moiety conjugates

#36
20110065631
2011-03-17

PROCESS FOR PREPARATION OF HIV PROTEASE INHIBITORS

#37
20100280264
2010-11-04

Production of organic solvent solutions of rare-earth organophosphates

#38
20100145075
2010-06-10

Process for the preparation of chymase modulators

#39
20100081634
2010-04-01

Novel Phosphorus-Containing Thyromimetics

#40
20100063311
2010-03-11

OLIGOMERIC PHOSPHONATE COMPOSITIONS, THEIR PREPARATION AND USES

#41
20100055164
2010-03-04

Synthetic lung surfactant and use thereof

#42
20090275535
2009-11-05

Antiviral phosphonate analogs

#43
20090258422
2009-10-15

Optically detectable organophosphonates

#44
20090118236
2009-05-07

Phosphorus-containing thyromimetics

#45
20090004293
2009-01-01

Phosphorous containing compounds including triphenylmethylphosphonate esters for the treatment of melanoma and other cancers

#46
20080004242
2008-01-03

Process for preparation of HIV protease inhibitors

#47
20070105823
2007-05-10

Glycero-compound having triple bond and membrane material containing the same

#48
20070083011
2007-04-12

Blocked mercaptosilane coupling agents for filled rubbers

#49
20070004833
2007-01-04

METHOD FOR THE PREPARATION OF ARALKYL DIALKYL PHOSPHONATES

#50
20060183866
2006-08-17

Blocked mercaptosilane coupling agents for filled rubbers

#51
20060156960
2006-07-20

Use of phosphorus-oxygen acid esters containing alkoxy groups as corrosion inhibitors for reinforced concrete

#52
20060135773
2006-06-22

Trisubstituted nitrogen modulators of tyrosine phosphatases

#53
20060134715
2006-06-22

Optically detectable organophosphonates

#54
20060122383
2006-06-08

Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine

#55
20060058259
2006-03-16

Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine

#56
20060046980
2006-03-02

Phosphorus-containing thyromimetics

#57
20060014870
2006-01-19

Blocked mercaptosilane coupling agents for filled rubbers

#58
20050267238
2005-12-01

Organophosphorus compounds having polysulfide bridge

#59
20050256078
2005-11-17

Inosine monophosphate dehydrogenase inhibitory phosphonate compounds

#60
20050215513
2005-09-29

Antiviral phosphonate analogs

#61
20050203306
2005-09-15

Preparation of halohydrocarbyl phosphonic acid diesters

#62
20050176982
2005-08-11

Method for producing onium salt derivatives, and novel onium salt derivatives

#63
20050123533
2005-06-09

Prodrugs activated by targeted catalytic proteins

#64
20050014971
2005-01-20

Enanitomers of unsaturated alkyllysophosphonocholines and use as anti-neoplastics